ARTICLES BY THIS AUTHOR
- 3/8/2022
Akorn, Théa Pharma complete branded ophthalmic products sale
Moving forward Akorn said it will invest in its facilities and targeted avenues of growth, such as its human generics and animal care businesses. - 3/8/2022
Hy-Vee dietitians host healthy lifestyle events throughout March
Through the end of March, the retailer’s registered dietitians will host events focused on nutrition and helping customers eat healthier on a budget. - 3/8/2022
CVS Health to reportedly trademark pharmacies, clinics in metaverse
CVS Health is seeking to patent its stores and sales of virtual goods, including prescription drugs, wellness, beauty and personal care products in the metaverse, according to a report. - 3/8/2022
NACDS addresses AMA criticism of pharmacy’s role in COVID-19 antivirals program
NACDS president and CEO Steve Anderson reacted to the AMA’s criticism of the role pharmacy-based clinics could play in the ‘test to treat’ antivirals program. - 3/7/2022
BD plans to spinoff its diabetes care business
Upon completion of the distribution, Embecta will be an independent and publicly traded company focused on diabetes management that BD will retain no ownership interest. - 3/7/2022
Walgreens, Labcorp offering at-home COVID-19 test collection kits
The collaboration between Walgreens and Labcorp expands access to convenient testing at no cost for eligible individuals. - 3/7/2022
Lannett to sell liquid drug manufacturing plant, other assets for $10.5M
The sale of Lannett’s liquid drug manufacturing facility in Carmel, N.Y., to a private company, is anticipated to close within the next several weeks. - 3/7/2022
Rite Aid restructures leadership division
The retailer is streamlining its operations by eliminating the chief operating officer role and consolidating its pharmacy leadership. - 3/6/2022
Michigan Gov. Whitmer signs bipartisan bills lowering prescription drug costs
House Bills 4348, 4351 and 4352 will lower the costs of prescription drugs for Michiganders and hold pharmacy benefit managers accountable. - 3/6/2022
Glenmark obtains FDA OK for generic MetroGel-Vaginal gel
MetroGel-Vaginal gel had a market value of approximately $60.4 million for the 12-month period ending November 2021, according to IQVIA.